UAE Syringe Market By Product Type (General {Insulin, Allergy, Tuberculin, Others}, Specialized {Auto-Disable, Active Safety, Passive Safety}, Smart), By Material (Plastic, Glass, Others), By Usage (Reusable v/s Disposable), By End User (Hospitals & Clinics, Blood Collection Centers, Diabetes Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027
UAE syringe market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing demands for injectable pharmaceuticals. Increasing demand for quick administration and immediate affecting drugs in the system is further driving the growth of the UAE syringe market in the upcoming five years. The rising geriatric population and their susceptibility toward diabetes and other chronic diseases also aid in the growth of the UAE syringe market in the next five years.
COVID-19 Upsurged Market Growth
Demands for syringes boomed suddenly with the vaccination availability all around the world. The COVID-19 infection was widespread and affected the United Arab Emirates too. Over 884 thousand people have by far accounted to be infected by the coronavirus while there were 2302 deaths between 2020-2021 due to COVID-19. The government soon started with the vaccination that aided the growing demand for syringes. By far, 24.2 million doses have already been given the vaccination which accounts for approximately 96.3% of the population is fully vaccinated. Although the cases of COVID-19 infection are still increasing the death toll has reduced since the vaccination, and the population has higher immunity and can recover.
Cancer Therapeutics Promises Market Growth
Therapeutic procedures like chemotherapy, for the treatment of cancer, have increased the demand for syringes. Increasing instances of cancer among the population of the country further aid the growth of the UAE syringe market in the upcoming five years. 4,807 new cancer cases were accounted for in the year 2020 including both male and female populations. With early detection of cancer, exposure to chemotherapy for a short duration of time makes the treatment efficient and effective. Rapidly growing preferences of the population toward chemotherapy over radiotherapy further aid the growth of the UAE syringe market in the next five years.
Insulin Pump Demands Upsurge Market Growth
Increasing instances of diabetes among the population of the country is further aiding the growth of the UAE syringe market in the upcoming five years. As of 2021, more than 1 million population is suffering from diabetes in the country. In every 6 babies born in the country, one has diabetes due to genetic mutations or due to their parents carrying the genes, thus affecting the population at large. The increasing demand for insulin injectables further substantiates the growth of the UAE syringe market in the next five years.
Market Segmentation
The UAE syringe market is segmented by product type, material, usage, end user, competitive landscape, and regional distribution. Based on product type, the market is further segmented into general, specialized, and smart. General products include insulin, allergy, tuberculin, and others. Specialized products include auto-disable, active safety, and passive safety. By material, the market is bifurcated into plastic, glass, and others. Based on usage the market is differentiated between reusable and disposable. By end user, the market is bifurcated into hospitals & clinics, blood collection centers, diabetes care centers, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, and the rest of UAE.
Company Profile
Becton Dickinson and Company, B. Braun Medical Gulf FZ – LLC, Medtronic Meta FZ-LLC, Nipro Middle East FZE, Baxter Healthcare UAE, Terumo Middle East FZE, Al Maqam Medical Supplies LLC, Abu Dhabi Medical Devices Company, Riomed Medical Supplies L.L.C, among others is a partial list of major market players of the companies responsible for the growth of UAE syringe market.
Report Scope:
In this report, UAE syringe market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in UAE syringe market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
COVID-19 Upsurged Market Growth
Demands for syringes boomed suddenly with the vaccination availability all around the world. The COVID-19 infection was widespread and affected the United Arab Emirates too. Over 884 thousand people have by far accounted to be infected by the coronavirus while there were 2302 deaths between 2020-2021 due to COVID-19. The government soon started with the vaccination that aided the growing demand for syringes. By far, 24.2 million doses have already been given the vaccination which accounts for approximately 96.3% of the population is fully vaccinated. Although the cases of COVID-19 infection are still increasing the death toll has reduced since the vaccination, and the population has higher immunity and can recover.
Cancer Therapeutics Promises Market Growth
Therapeutic procedures like chemotherapy, for the treatment of cancer, have increased the demand for syringes. Increasing instances of cancer among the population of the country further aid the growth of the UAE syringe market in the upcoming five years. 4,807 new cancer cases were accounted for in the year 2020 including both male and female populations. With early detection of cancer, exposure to chemotherapy for a short duration of time makes the treatment efficient and effective. Rapidly growing preferences of the population toward chemotherapy over radiotherapy further aid the growth of the UAE syringe market in the next five years.
Insulin Pump Demands Upsurge Market Growth
Increasing instances of diabetes among the population of the country is further aiding the growth of the UAE syringe market in the upcoming five years. As of 2021, more than 1 million population is suffering from diabetes in the country. In every 6 babies born in the country, one has diabetes due to genetic mutations or due to their parents carrying the genes, thus affecting the population at large. The increasing demand for insulin injectables further substantiates the growth of the UAE syringe market in the next five years.
Market Segmentation
The UAE syringe market is segmented by product type, material, usage, end user, competitive landscape, and regional distribution. Based on product type, the market is further segmented into general, specialized, and smart. General products include insulin, allergy, tuberculin, and others. Specialized products include auto-disable, active safety, and passive safety. By material, the market is bifurcated into plastic, glass, and others. Based on usage the market is differentiated between reusable and disposable. By end user, the market is bifurcated into hospitals & clinics, blood collection centers, diabetes care centers, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, and the rest of UAE.
Company Profile
Becton Dickinson and Company, B. Braun Medical Gulf FZ – LLC, Medtronic Meta FZ-LLC, Nipro Middle East FZE, Baxter Healthcare UAE, Terumo Middle East FZE, Al Maqam Medical Supplies LLC, Abu Dhabi Medical Devices Company, Riomed Medical Supplies L.L.C, among others is a partial list of major market players of the companies responsible for the growth of UAE syringe market.
Report Scope:
In this report, UAE syringe market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- UAE Syringe Market, By Product Type:
- General
- Insulin
- Allergy
- Tuberculin
- Others
- Specialized
- Auto-Disable
- Active Safety
- Passive Safety
- Smart
- UAE Syringe Market, By Material:
- Plastic
- Glass
- Others
- UAE Syringe Market, By Usage:
- Reusable
- Disposable
- UAE Syringe Market, By End User:
- Hospitals & Clinics
- Blood Collection Centers
- Diabetes Care Centers
- Others
- UAE Syringe Market, By Region:
- Abu Dhabi
- Dubai
- Sharjah
- Rest of UAE
Company Profiles: Detailed analysis of the major companies present in UAE syringe market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE SYRINGE MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. UAE SYRINGE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (General, Specialized, Smart)
6.2.2. By Material (Plastic, Glass, Others)
6.2.3. By Usage (Reusable v/s Disposable)
6.2.4. By End User (Hospitals & Clinics, Blood Collection Centers, Diabetes Care Centers, Others)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. UAE GENERAL SYRINGE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Insulin, Allergy, Tuberculin, Others)
7.2.2. By Material
7.2.3. By Usage
7.2.4. By End User
8. UAE SPECIALIZED SYRINGE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Auto-Disable, Active Safety, Passive Safety)
8.2.2. By Material
8.2.3. By Usage
8.2.4. By End User
9. UAE SMART SYRINGE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Material
9.2.2. By Usage
9.2.3. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. PRICING ANALYSIS
14. IMPORT-EXPORT ANALYSIS
15. UAE ECONOMIC PROFILE
16. COMPETITIVE LANDSCAPE
16.1. Competition Outlook
16.2. Company Profiles
16.2.1. Becton Dickinson and Company
16.2.2. B. Braun Medical Gulf FZ - LLC
16.2.3. Medtronic Meta FZ-LLC
16.2.4. Nipro Middle East FZE
16.2.5. Baxter Healthcare UAE
16.2.6. Terumo Middle East FZE
16.2.7. Al Maqam Medical Supplies LLC
16.2.8. Abu Dhabi Medical Devices Company
16.2.9. Riomed Medical Supplies L.L.C
17. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE SYRINGE MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. UAE SYRINGE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (General, Specialized, Smart)
6.2.2. By Material (Plastic, Glass, Others)
6.2.3. By Usage (Reusable v/s Disposable)
6.2.4. By End User (Hospitals & Clinics, Blood Collection Centers, Diabetes Care Centers, Others)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. UAE GENERAL SYRINGE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Insulin, Allergy, Tuberculin, Others)
7.2.2. By Material
7.2.3. By Usage
7.2.4. By End User
8. UAE SPECIALIZED SYRINGE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Auto-Disable, Active Safety, Passive Safety)
8.2.2. By Material
8.2.3. By Usage
8.2.4. By End User
9. UAE SMART SYRINGE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Material
9.2.2. By Usage
9.2.3. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. PRICING ANALYSIS
14. IMPORT-EXPORT ANALYSIS
15. UAE ECONOMIC PROFILE
16. COMPETITIVE LANDSCAPE
16.1. Competition Outlook
16.2. Company Profiles
16.2.1. Becton Dickinson and Company
16.2.2. B. Braun Medical Gulf FZ - LLC
16.2.3. Medtronic Meta FZ-LLC
16.2.4. Nipro Middle East FZE
16.2.5. Baxter Healthcare UAE
16.2.6. Terumo Middle East FZE
16.2.7. Al Maqam Medical Supplies LLC
16.2.8. Abu Dhabi Medical Devices Company
16.2.9. Riomed Medical Supplies L.L.C
17. STRATEGIC RECOMMENDATIONS
